A Patient Diagnosed with STEMI Is About to Undergo a Primary

question 12

Multiple Choice

A patient diagnosed with STEMI is about to undergo a primary percutaneous coronary intervention (PCI) . Which combination of pharmacotherapeutic agents will be given to augment this procedure?

• A) Beta blocker and nitroglycerin
• B) Abciximab and a fibrinolytic drug
• C) Angiotensin-converting enzyme (ACE) inhibitor and aspirin
• D) Heparin, aspirin, and clopidogrel

---

Definitions:

Bacterial Infections

Diseases caused by harmful bacteria entering the body and multiplying, potentially leading to illness.

Stress Hormones

Biochemical substances, such as cortisol and adrenaline, released into the body in response to stress, affecting various physical and mental functions.

Cancer Cells

Abnormal cells that divide uncontrollably, can invade nearby tissues, and may spread to other parts of the body through the blood and lymph system.

Suppressed Lymphocyte Activity

A condition where the activity of lymphocytes, a type of white blood cell crucial for immune response, is reduced, potentially impairing the body's ability to fight infections.